Ondine Historical Balance Sheet

OBI Stock

10.25 0.25 2.50%

Trend analysis of Ondine Biomedical balance sheet accounts such as Property Plant And Equipment Net of 663.6 K provides information on Ondine Biomedical's total assets, liabilities, and equity, which is the actual value of Ondine Biomedical to its prevalent stockholders. By breaking down trends over time using Ondine Biomedical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Ondine Biomedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ondine Biomedical is a good buy for the upcoming year.

Ondine Biomedical Inventory

646,170

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Ondine Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Ondine Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Ondine Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ondine Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ondine currently owns. An asset can also be divided into two categories, current and non-current.

Ondine Biomedical Balance Sheet Chart

At present, Ondine Biomedical's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Cash is expected to grow to about 4.5 M, whereas Property Plant And Equipment Net is forecasted to decline to about 663.6 K.

Total Assets Total Current Liabilities Property Plant And Equipment Net Accounts Payable Capital Stock

Add Fundamental

Total Assets

Total assets refers to the total amount of Ondine Biomedical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ondine Biomedical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Ondine Biomedical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ondine Biomedical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Accounts Payable

An accounting item on the balance sheet that represents Ondine Biomedical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ondine Biomedical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Most accounts from Ondine Biomedical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Ondine Biomedical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2022	2023	2024	2025 (projected)
Total Current Liabilities	3.9M	3.5M	4.0M	3.8M
Total Assets	16.6M	5.7M	6.6M	9.0M

Total Current Liabilities Total Assets

Ondine Biomedical balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Other Current Assets	Short Term Debt	Inventory	Intangible Assets	Short Term Investments	Capital Surpluse	Common Stock
Total Assets		-0.38	0.78	0.28	-0.8	-0.49	0.41	1.0	-0.43	-0.21	1.0	0.23	-0.27	-0.08	0.39	-0.36	1.0	-0.43	0.32	0.89	-0.43	0.58	-0.31	-0.2	0.17	0.52
Total Current Liabilities	-0.38		-0.87	-0.17	0.85	0.1	-0.5	-0.36	0.15	-0.31	-0.37	0.24	0.31	0.29	-0.04	1.0	-0.38	0.99	0.29	-0.24	0.99	-0.45	0.21	-0.34	0.34	-0.44
Total Stockholder Equity	0.78	-0.87		0.24	-0.99	-0.31	0.55	0.77	-0.31	0.1	0.78	-0.07	-0.37	-0.23	0.2	-0.86	0.78	-0.89	-0.04	0.62	-0.89	0.61	-0.29	0.12	-0.12	0.54
Property Plant And Equipment Net	0.28	-0.17	0.24		-0.33	-0.71	0.32	0.32	-0.76	-0.07	0.33	0.47	0.11	-0.14	0.82	-0.14	0.35	-0.24	0.63	0.32	-0.25	0.63	-0.81	-0.1	0.11	0.69
Net Debt	-0.8	0.85	-0.99	-0.33		0.37	-0.57	-0.79	0.41	-0.1	-0.8	-0.04	0.36	0.24	-0.3	0.84	-0.8	0.88	-0.06	-0.67	0.88	-0.64	0.38	-0.11	0.12	-0.6
Retained Earnings	-0.49	0.1	-0.31	-0.71	0.37		-0.68	-0.47	0.54	0.66	-0.48	-0.56	-0.52	0.03	-0.89	0.09	-0.52	0.2	-0.64	-0.64	0.21	-0.83	0.45	0.64	-0.59	-0.89
Accounts Payable	0.41	-0.5	0.55	0.32	-0.57	-0.68		0.38	-0.37	-0.38	0.39	0.28	0.26	-0.13	0.56	-0.5	0.43	-0.56	0.16	0.56	-0.57	0.73	-0.26	-0.4	0.4	0.79
Cash	1.0	-0.36	0.77	0.32	-0.79	-0.47	0.38		-0.49	-0.15	1.0	0.26	-0.33	-0.07	0.41	-0.34	1.0	-0.41	0.35	0.89	-0.42	0.56	-0.38	-0.14	0.13	0.5
Non Current Assets Total	-0.43	0.15	-0.31	-0.76	0.41	0.54	-0.37	-0.49		-0.18	-0.5	-0.73	0.27	0.04	-0.8	0.13	-0.51	0.23	-0.61	-0.6	0.24	-0.34	0.97	-0.18	0.18	-0.6
Non Currrent Assets Other	-0.21	-0.31	0.1	-0.07	-0.1	0.66	-0.38	-0.15	-0.18		-0.15	-0.21	-0.83	-0.06	-0.37	-0.32	-0.18	-0.26	-0.35	-0.33	-0.25	-0.51	-0.32	0.98	-0.91	-0.41
Cash And Short Term Investments	1.0	-0.37	0.78	0.33	-0.8	-0.48	0.39	1.0	-0.5	-0.15		0.27	-0.32	-0.08	0.42	-0.35	1.0	-0.42	0.35	0.9	-0.42	0.56	-0.39	-0.14	0.12	0.52
Net Receivables	0.23	0.24	-0.07	0.47	-0.04	-0.56	0.28	0.26	-0.73	-0.21	0.27		0.14	-0.12	0.76	0.26	0.3	0.13	0.83	0.56	0.13	0.2	-0.63	-0.18	0.14	0.47
Common Stock Shares Outstanding	-0.27	0.31	-0.37	0.11	0.36	-0.52	0.26	-0.33	0.27	-0.83	-0.32	0.14		0.06	0.33	0.3	-0.28	0.26	0.22	-0.09	0.26	0.32	0.3	-0.78	0.71	0.36
Non Current Liabilities Total	-0.08	0.29	-0.23	-0.14	0.24	0.03	-0.13	-0.07	0.04	-0.06	-0.08	-0.12	0.06		-0.04	0.29	-0.08	0.3	-0.01	-0.08	0.3	-0.12	0.09	-0.08	0.08	-0.12
Other Stockholder Equity	0.39	-0.04	0.2	0.82	-0.3	-0.89	0.56	0.41	-0.8	-0.37	0.42	0.76	0.33	-0.04		-0.01	0.46	-0.14	0.72	0.63	-0.15	0.62	-0.75	-0.35	0.29	0.87
Total Liab	-0.36	1.0	-0.86	-0.14	0.84	0.09	-0.5	-0.34	0.13	-0.32	-0.35	0.26	0.3	0.29	-0.01		-0.36	0.99	0.31	-0.23	0.99	-0.44	0.19	-0.34	0.34	-0.42
Total Current Assets	1.0	-0.38	0.78	0.35	-0.8	-0.52	0.43	1.0	-0.51	-0.18	1.0	0.3	-0.28	-0.08	0.46	-0.36		-0.43	0.37	0.91	-0.43	0.59	-0.4	-0.17	0.15	0.56
Short Long Term Debt Total	-0.43	0.99	-0.89	-0.24	0.88	0.2	-0.56	-0.41	0.23	-0.26	-0.42	0.13	0.26	0.3	-0.14	0.99	-0.43		0.18	-0.32	1.0	-0.52	0.28	-0.28	0.29	-0.53
Other Current Liab	0.32	0.29	-0.04	0.63	-0.06	-0.64	0.16	0.35	-0.61	-0.35	0.35	0.83	0.22	-0.01	0.72	0.31	0.37	0.18		0.46	0.17	0.46	-0.53	-0.39	0.39	0.43
Other Current Assets	0.89	-0.24	0.62	0.32	-0.67	-0.64	0.56	0.89	-0.6	-0.33	0.9	0.56	-0.09	-0.08	0.63	-0.23	0.91	-0.32	0.46		-0.33	0.53	-0.45	-0.28	0.21	0.67
Short Term Debt	-0.43	0.99	-0.89	-0.25	0.88	0.21	-0.57	-0.42	0.24	-0.25	-0.42	0.13	0.26	0.3	-0.15	0.99	-0.43	1.0	0.17	-0.33		-0.53	0.29	-0.28	0.28	-0.54
Inventory	0.58	-0.45	0.61	0.63	-0.64	-0.83	0.73	0.56	-0.34	-0.51	0.56	0.2	0.32	-0.12	0.62	-0.44	0.59	-0.52	0.46	0.53	-0.53		-0.28	-0.55	0.57	0.8
Intangible Assets	-0.31	0.21	-0.29	-0.81	0.38	0.45	-0.26	-0.38	0.97	-0.32	-0.39	-0.63	0.3	0.09	-0.75	0.19	-0.4	0.28	-0.53	-0.45	0.29	-0.28		-0.32	0.32	-0.56
Short Term Investments	-0.2	-0.34	0.12	-0.1	-0.11	0.64	-0.4	-0.14	-0.18	0.98	-0.14	-0.18	-0.78	-0.08	-0.35	-0.34	-0.17	-0.28	-0.39	-0.28	-0.28	-0.55	-0.32		-0.98	-0.36
Capital Surpluse	0.17	0.34	-0.12	0.11	0.12	-0.59	0.4	0.13	0.18	-0.91	0.12	0.14	0.71	0.08	0.29	0.34	0.15	0.29	0.39	0.21	0.28	0.57	0.32	-0.98		0.29
Common Stock	0.52	-0.44	0.54	0.69	-0.6	-0.89	0.79	0.5	-0.6	-0.41	0.52	0.47	0.36	-0.12	0.87	-0.42	0.56	-0.53	0.43	0.67	-0.54	0.8	-0.56	-0.36	0.29

Click cells to compare fundamentals

Ondine Biomedical Account Relationship Matchups

Ondine Biomedical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.6M	34.1M	16.6M	5.7M	6.6M	9.0M
Total Current Liabilities	35.8M	3.9M	3.9M	3.5M	4.0M	3.8M
Total Stockholder Equity	(33.8M)	29.7M	11.6M	2.1M	1.9M	2.0M
Property Plant And Equipment Net	671K	601K	1.4M	949K	1.1M	663.6K
Net Debt	30.8M	(29.6M)	(12.2M)	(2.4M)	(2.8M)	(2.7M)
Retained Earnings	(182.1M)	(232.5M)	(251.9M)	(266.3M)	(239.7M)	(227.7M)
Accounts Payable	237K	1.2M	388K	1.4M	1.6M	923.0K
Cash	626K	30.4M	13.1M	3.0M	3.4M	4.5M
Non Current Assets Total	888K	636K	1.4M	984K	1.1M	1.3M
Non Currrent Assets Other	40K	46K	35K	36K	31.5K	29.9K
Cash And Short Term Investments	626K	30.4M	13.1M	3.0M	3.4M	5.6M
Net Receivables	543K	248K	133K	220K	198K	269.6K
Liabilities And Stockholders Equity	2.6M	34.1M	16.6M	5.7M	6.6M	9.0M
Non Current Liabilities Total	678K	561K	1.0M	159K	182.9K	173.7K
Other Stockholder Equity	28.8M	27.2M	28.5M	28.8M	33.1M	33.0M
Total Liab	36.5M	4.5M	4.9M	3.6M	4.2M	4.0M
Total Current Assets	1.7M	33.5M	15.1M	4.8M	5.5M	7.7M
Short Long Term Debt Total	31.5M	739K	896K	541K	622.2K	591.0K
Other Current Liab	4.2M	2.1M	3.2M	1.7M	2.0M	1.0M
Other Current Assets	717K	2.1M	710K	703K	632.7K	1.1M
Short Term Debt	31.4M	645K	359K	382K	439.3K	417.3K
Inventory	404K	1.1M	1.3M	1.1M	1.2M	646.2K
Capital Lease Obligations	310K	242K	896K	541K	622.2K	469.7K
Net Invested Capital	334K	30.2M	11.6M	2.1M	2.4M	2.3M
Net Working Capital	(34.0M)	29.6M	11.2M	1.3M	1.4M	1.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Other Information on Investing in Ondine Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ondine Historical Balance Sheet

Ondine Biomedical Inventory

646,170

About Ondine Balance Sheet Analysis

Ondine Biomedical Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Accounts Payable

Capital Stock

Ondine Biomedical balance sheet Correlations

Ondine Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ondine Biomedical balance sheet Accounts

Also Currently Popular

Other Information on Investing in Ondine Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Net Debt	- 0.99	Total Stockholder Equity
Capital Surpluse	- 0.98	Short Term Investments
Capital Surpluse	- 0.91	Non Currrent Assets Other
Common Stock	- 0.89	Retained Earnings
Other Stockholder Equity	- 0.89	Retained Earnings
Short Term Debt	- 0.89	Total Stockholder Equity